21 research outputs found
Effect of nitrogen and phosphorus sources on amylase production in seed born fungi of maize
Starch degrading amylolytic enzymes are of great significance in biotechnological application ranging from food, fermentation, and textile to paper industries. Amylase enzyme action of ten dominating fungi viz. Alternaria alternata, Aspergillus flavus, A niger, A terrus, Curvularia lunata, Fusarium oxysporum, Helminthosporium tetramera, Penicillium notatum, Rhizoctonia solani & Trichoderma viride isolated from different varieties of maize seeds were studies under the influences of nitrogen & phosphorus sources. The results are very helpful to minimize the bio-deterioration of maize seeds in different storage condition. 
Design of electron beam bending magnet system for electron and photon therapy: A simulation approach
The doubly achromatic electron beam bending magnet system using two sector magnets has been designed for the medical applications to treat the cancer. The aim of electron beam bending magnet system is to focus an electron beam having a spot size less than 3 mm × 3 mm, energy spread within 3% and divergence angle ≤ 3mrad at the target position. To achieve these parameters, the simulation has been carried out using Lorentz-3EM software. The beam spot, divergence angle and energy spread have been observed with respect to the variation in angles of sector magnets and drift distance. Based on the simulated results, it has been optimized that the first and second magnet has an angle 206° and 35° and the drift distance 80 mm. It is also observed that at the 1125, 1762, 2570, 3265 and 4155 Amp-turn, the optimized design produces 3369, 4972, 6384, 7584 and 9568 Gauss of magnetic field at median plane which require to bend 6, 9, 12, 15 and 18 MeV energy of electron, respectively, for the electron therapy application. The output beam parameters of the optimized design are energy spread ±3%, divergence angle ~3 mrad and spot size 2.6 mm. Moreover, for 6 MV and 15 MV photon therapy applications, an electron beam of energy 6.5 MeV and 15.5 MeV extracted from magnet system and focused on the bremsstrahlung target. Various materials have been studied for photon generation using Monte Carlo based Fluka code and Tungsten material has been optimized as bremsstrahlung target which produces continuous energy bremsstrahlung spectrum. For the photon therapy, the 1233 and 3327 amp-turn, in an optimized design produces 3616 and 7785 Gauss of magnetic field at median plane require to bend 6.5 and 15.5 MeV energy of electron, respectively, which further produces bremsstrahlung radiation from Tungsten target
Collaborating around digital tabletops: children’s physical strategies from the UK, India and Finland
We present a study of children collaborating around interactive tabletops in three different countries: the United Kingdom, India and Finland. Our data highlights the key distinctive physical strategies used by children when performing collaborative tasks during this study. Children in the UK tend to prefer static positioning with minimal physical contact and simultaneous object movement. Children in India employed dynamic positioning with frequent physical contact and simultaneous object movement. Children in Finland used a mixture of dynamic and static positioning with minimal physical contact and object movement. Our findings indicate the importance of understanding collaboration strategies and behaviours when designing and deploying interactive tabletops in heterogeneous educational environments. We conclude with a discussion on how designers of tabletops for schools can provide opportunities for children in different countries to define and shape their own collaboration strategies for small group learning that take into account their different classroom practices
The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019
Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe
Antibodies against endogenous retroviruses promote lung cancer immunotherapy
B cells are frequently found in the margins of solid tumours as organized follicles in ectopic lymphoid organs called tertiary lymphoid structures (TLS). Although TLS have been found to correlate with improved patient survival and response to immune checkpoint blockade (ICB), the underlying mechanisms of this association remain elusive. Here we investigate lung-resident B cell responses in patients from the TRACERx 421 (Tracking Non-Small-Cell Lung Cancer Evolution Through Therapy) and other lung cancer cohorts, and in a recently established immunogenic mouse model for lung adenocarcinoma. We find that both human and mouse lung adenocarcinomas elicit local germinal centre responses and tumour-binding antibodies, and further identify endogenous retrovirus (ERV) envelope glycoproteins as a dominant anti-tumour antibody target. ERV-targeting B cell responses are amplified by ICB in both humans and mice, and by targeted inhibition of KRAS(G12C) in the mouse model. ERV-reactive antibodies exert anti-tumour activity that extends survival in the mouse model, and ERV expression predicts the outcome of ICB in human lung adenocarcinoma. Finally, we find that effective immunotherapy in the mouse model requires CXCL13-dependent TLS formation. Conversely, therapeutic CXCL13 treatment potentiates anti-tumour immunity and synergizes with ICB. Our findings provide a possible mechanistic basis for the association of TLS with immunotherapy response
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
A versatile access to calystegine analogues as potential glycosidases inhibitors
An efficient metathetic strategy and nitrone chemistry have been suitably tethered to construct 8-azabicyclo[3.2.1]octanes as versatile precursors for the synthesis of several calystegine analogues. This synthetic strategy relies on the ability of mannose-derived nitrone to undergo a highly stereoselective nucleophilic addition of various Grignard reagents to access syn orientation of alkenes, which then smoothly undergo ring-closing metathesis (RCM) to provide this framework. These RCM products 18 and 20 have been successfully used as advance precursors to synthesize many calystegine analogues (27, 36, 38, 40, 43, and 44) either by syn-dihydroxylation or by hydrogenation and followed by global deprotection. Interestingly, both compounds 36 and 40 exhibited significant noncompetitive inhibition against α-mannosidase and N-acetyl-β-D-glucosaminidase
Synthesis of new six- and seven-membered 1-N-iminosugar as promising glycosidase inhibitors
New six- and seven-membered 1-N-iminosugars were prepared from D-glucose by the stereoselective Michael addition of nitromethane to D-glucose derived α,β-unsaturated ester A followed by one pot reduction of nitro/ester functionality and subsequent amine protection to get N-Cbz protected aminol 6. Hydrolysis of 1,2-acetonide and reductive aminocyclization gave seven membered 1-N-iminosugar 5b. While, hydrolysis of 1,2-acetonide followed by NaIO4 oxidative cleavage and hydrogenation using 10% Pd(OH)2/C, H2 gave six membered 1-N-iminosugar 4a; the hydrogenation using 10% Pd/C-H2 however, gave N-methyl substituted 1-N-iminosugar 4b. The hydrochloride salts of 4a/4b and 5b were found to be specific α-galactosidase and moderate α-glucosidae inhibitors, respectively, in micro molar range